Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Washington Roundup, November-December 2012

Executive Summary

The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.” This month we cover the post-election picture, pending reimbursement reductions for interventional cardiologists, and new guidance on PMA and 510(k) submission reviews.

Advertisement

Related Content

Device Industry Amps Up Efforts To Repeal Device Tax In Lame Duck Session
News In Brief
Multiple MDUFA Policies In Transition Phase Until Jan. 1
CMS Catches Criticism For Continued Delays With Sunshine Rule
New Coverage-With-Evidence-Development Guidance In The Works Following MedCAC Meeting
Device Firms Seek More Exemptions, Pricing Flexibility For Oncoming Excise Tax
FDA Agrees To Waive User Fees For Reviews Of Lab-Developed Tests
Device Industry Expects Quicker Path To Market In Exchange For Doubling Of User Fees
Changing The Paradigm: 510(k) Draft Guidance May Raise New Questions
CMS Cuts Advanced Imaging Payments In 2012 Physician Fee Schedule

Topics

Advertisement
UsernamePublicRestriction

Register

MT035496

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel